Holen Sie sich die Stockscreener-App
6.63
2.07%
-0.14
Handel nachbörslich:
6.62
-0.010
-0.15%
Schlusskurs vom Vortag:
$6.77
Offen:
$6.8
24-Stunden-Volumen:
515.87K
Relative Volume:
1.04
Marktkapitalisierung:
$124.41M
Einnahmen:
$109.43M
Nettoeinkommen (Verlust:
$5.13M
KGV:
25.44
EPS:
0.2606
Netto-Cashflow:
$18.91M
1W Leistung:
+3.59%
1M Leistung:
+1.07%
6M Leistung:
-65.40%
1J Leistung:
-31.15%
1-Tages-Spanne:
$6.46
$6.8923
1-Wochen-Bereich:
$5.95
$6.99
52-Wochen-Spanne:
$5.54
$22.25
Optimizerx Corp Stock (OPRX) Company Profile
Firmenname
Optimizerx Corp
Sektor
Branche
Telefon
248-651-6558
Adresse
260 CHARLES STREET, WALTHAM, MI
Compare OPRX vs VEEV, BTSG, TEM, HQY, DOCS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
6.63 | 127.04M | 109.43M | 5.13M | 18.91M | 0.2606 |
VEEV
Veeva Systems Inc
|
171.19 | 27.80B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
51.44 | 10.38B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
54.07 | 10.01B | 1.27B | -245.03M | -245.36M | -1.4071 |
HQY
Healthequity Inc
|
82.63 | 6.94B | 1.31B | 215.20M | 408.32M | 2.4627 |
DOCS
Doximity Inc
|
25.77 | 4.60B | 637.78M | 239.40M | 307.21M | 1.1909 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-08 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-07-25 | Fortgesetzt | B. Riley Securities | Buy |
| 2024-04-04 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-02-02 | Fortgesetzt | B. Riley Securities | Buy |
| 2022-11-01 | Eingeleitet | Stifel | Buy |
| 2022-07-15 | Eingeleitet | SVB Leerink | Outperform |
| 2021-10-18 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-04-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2019-01-03 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Optimizerx Corp Aktie (OPRX) Neueste Nachrichten
Earnings preview: OptimizeRx Corp. (OPRX) Q1 earnings expected to decline - MSN
OptimizeRx (OPRX) Projected to Post Earnings on Tuesday - MarketBeat
Earnings Preview: OptimizeRx Corp. (OPRX) Q1 Earnings Expected to Decline - Yahoo Finance
Are Investors Undervaluing OptimizeRx (OPRX) Right Now? - Yahoo Finance
OptimizeRx (OPRX) price target decreased by 40.41% to 14.79 - MSN
OPRX Technical Analysis & Stock Price Forecast - Intellectia AI
OPRX SEC FilingsOptimizerx Corp 10-K, 10-Q, 8-K Forms - Stock Titan
[ARS] OptimizeRx Corp SEC Filing - Stock Titan
OptimizeRx (OPRX) sets 2026 virtual meeting, equity plan expansion and pay votes - Stock Titan
OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report - marketscreener.com
OptimizeRx (OPRX) soars 5.9%: Is further upside left in the stock? - MSN
OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ET - The Manila Times
OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4: 30 p.m. ET - marketscreener.com
OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 P.m. ET - Moomoo
OPRX OptimizeRx Corporation posts 120.6 percent Q4 2025 EPS surprise, shares rise modestly in today’s trading. - Newser
OptimizeRx (OPRX) Price Target Increased by 24.79% to 24.82 - MSN
OptimizeRx vs. GoodRx: Which Digital Health Stock is the Better Buy? - TradingView
JMP Securities Maintains OptimizeRx (OPRX) Market Outperform Recommendation - MSN
Will Enterprise Deals & MedTech Momentum Fuel OPRX's Growth Engine? - TradingView
OptimizeRx Corp. (NASDAQ:OPRX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
New OptimizeRx Corp (OPRX) director registers insider status with Form 3 - Stock Titan
Can OptimizeRx's Cash Strength Cushion Near-Term Headwinds? - Yahoo Finance
OptimizeRx Corporation (OPRX) Stock Hits 52-Week High (Weakens) 2026-04-20Institutional Buying - Newser
How The OptimizeRx (OPRX) Narrative Is Shifting As Revenue Caution Meets Profit Optimism - Yahoo Finance
OPRX Trades at a Discount to Industry: How to Approach the Stock Now? - TradingView
Should Value Investors Buy OptimizeRx (OPRX) Stock? - Yahoo Finance
Medical robotics firm Myomo taps ex-OptimizeRx chief for board seat - Stock Titan
OptimizeRx Corp. (NASDAQ:OPRX) Sees Significant Growth in Short Interest - MarketBeat
OPRX Cuts Revenue Outlook: Temporary Reset or Structural Concern? - qz.com
If You Invested $1,000 in Optimizerx Corp (OPRX) - Stock Titan
Whats the profit margin of OptimizeRx Corporation2026 Price Targets & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
OptimizeRx Corp. Receives Favorable Valuation Adjustment Amidst Profit Growth and High Institutional Confidence - Markets Mojo
OptimizeRx Adds Microsoft Health Leader to Board - TipRanks
OptimizeRx adds Microsoft Health exec to board of directors By Investing.com - Investing.com Australia
OptimizeRx adds Microsoft Health exec to board of directors - Investing.com
Microsoft health leader joins OptimizeRx (OPRX) board as independent director - Stock Titan
OptimizeRx Appoints Microsoft Health & Life Sciences COO to Board - National Today
OptimizeRx Appoints Mary Varghese Presti to Board of Directors - Bitget
OptimizeRx Taps Microsoft AI Leader for Board to Supercharge Growth - BriefGlance
Microsoft Health COO joins OptimizeRx board in director refresh - Stock Titan
List of 3 Acquisitions by OptimizeRx (Apr 2026) - Tracxn
Best Value Stocks to Buy for March 16th - Eastern Progress
What Makes OptimizeRx Corp. (OPRX) a Strong Momentum Stock: Buy Now? - MSN
Finanzdaten der Optimizerx Corp-Aktie (OPRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.66%
1.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):